Globus Medical, Inc. (GMED)
78.00
+1.36
(+1.77%)
USD |
NYSE |
May 18, 14:41
Globus Medical Research and Development Expense (Quarterly) : 36.51M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 361.60M |
| Edwards Lifesciences Corp. | 263.30M |
| Envista Holdings Corp. | 30.00M |
| ResMed, Inc. | 94.27M |
| West Pharmaceutical Services, Inc. | 15.80M |